24 early-stage NJ companies to receive $75M from NOL Program
NJEDA said 24 early-stage technology and biotech companies were approved to participate in this year’s Net Operating Loss (NOL) Program.
Stay updated with breaking news from Celsion Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NJEDA said 24 early-stage technology and biotech companies were approved to participate in this year’s Net Operating Loss (NOL) Program.
Celsion Corp. announced a new name it says better reflects its work developing immunotherapies and next-generation vaccines.
Research analysts at HC Wainwright initiated coverage on shares of Celsion (NASDAQ:CLSN – Get Rating) in a report issued on Wednesday, The Fly reports. The firm set a “buy” rating on the biotechnology company’s stock. Separately, StockNews.com started coverage on shares of Celsion in a report on Monday. They issued a “hold” rating for the […]
StockNews.com began coverage on shares of Celsion (NASDAQ:CLSN – Get Rating) in a report issued on Monday. The brokerage set a “hold” rating on the biotechnology company’s stock. CLSN opened at $3.92 on Monday. The stock has a market capitalization of $22.62 million, a P/E ratio of -1.01 and a beta of 2.11. The company […]
Celsion Co. (NASDAQ:CLSN – Get Rating) Director Frederick J. Fritz acquired 5,000 shares of the firm’s stock in a transaction on Friday, April 8th. The shares were bought at an average cost of $4.05 per share, with a total value of $20,250.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, […]